[Clinical experience with ceftizoxime in the pediatric field (author's transl)].
Ceftizoxime (CZX) was given intravenously to 28 children with the following acute bacterial infections; 15 cases of bronchopneumonia, 4 cases of urinary tract infection, 3 cases of purulent meningitis, 2 cases of acute tonsillitis, each 1 case of purulent cervical lymphadenitis and acute tonsillitis, orbital cellulitis, abscess of eyelid, and peritonitis. Out of 28 patients, good clinical responses were obtained in 26 patients, and bacteriological effectiveness was seen in all 14 cases. Side effects with CZX were observed in 2 cases; 1 case was drug fever, and the other case was eosinophilia. From the above clinical results, CZX is useful antibiotic for treating the pediatric patients with various kinds of bacterial infections.
D000367:Age Factors; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D015296:Ceftizoxime; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male
D015296:Ceftizoxime; D002439:Cefotaxime